Jamshid S Khorashad (Jamshid Khorashad)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Venues

Leukemia

British journal of haematology

Cancers

Cells

Imperial College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Imperial College London Jun 01 2006 - May 10 2010

United Kingdom

PHD :: Medicine

Publications

Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia (2024)
Seyed Mohammadreza Bolandi, Mahdi Pakjoo, Peyman Beigi, Mohammad Kiani, Ali Allahgholipour, Negar Goudarzi, Jamshid S Khorashad, Anna M Eiring
A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia. Cells 10 (11) (2021)
Sara Ribeiro, Anna M Eiring, Jamshid S Khorashad
Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia. Cancers 13 (20) (2021)
Clinton C Mason, Carme R Fiol, Monika J Baker, Elisabet Nadal-Melsio, Eva Yebra-Fernandez, Luciana Bicalho, Avirup Chowdhury, Michael Albert, Alistair G Reid, Simone Claudiani, Jane F Apperley, Jamshid S Khorashad
Identification of genetic targets in acute myeloid leukaemia for designing targeted therapy. British journal of haematology 192 (1) (2020)
Simone Claudiani, Jane F Apperley, Richard Szydlo, Afzal Khan, George Nesr, Chloe Hayden, Andrew J Innes, Kathy Dominy, Pierre Foskett, Letizia Foroni, Jamshid S Khorashad, Dragana Milojkovic
TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia. British journal of haematology 193 (2) (2020)
Avirup Chowdhury, Sandra Loaiza, Eva Yebra-Fernandez, Elisabet Nadal-Melsio, Jane F Apperley, Jamshid S Khorashad
An ex vivo investigation of interactions between primary acute myeloid leukaemia and mesenchymal stromal cells yields novel therapeutic targets. British journal of haematology 190 (4) (2020)
Mahroo Karimpoor, Eranka IIlangakoon, Alistair G Reid, Simone Claudiani, Mohan Edirisinghe, Jamshid S Khorashad
Development of artificial bone marrow fibre scaffolds to study resistance to anti-leukaemia agents. British journal of haematology 182 (6) (2017)

Jamshid S Khorashad.css-eqlu8i{font-size:small;padding-left:4px;} (Jamshid Khorashad)

Publication Activity (10 Years)

Top Topics

Top Venues

Jamshid S Khorashad (Jamshid Khorashad)